Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.617
+0.007 (1.15%)
At close: Feb 21, 2025, 4:00 PM
0.620
+0.003 (0.49%)
After-hours: Feb 21, 2025, 5:50 PM EST
Unicycive Therapeutics Market Cap
Unicycive Therapeutics has a market cap or net worth of $64.03 million as of February 21, 2025. Its market cap has increased by 69.03% in one year.
Market Cap
64.03M
Enterprise Value
32.49M
1-Year Change
69.03%
Ranking
Category
Stock Price
$0.62
Market Cap Chart
Since the IPO on July 13, 2021, Unicycive Therapeutics's market cap has decreased from $66.49M to $64.03M, a decrease of -3.70%. That is a compound annual growth rate of -1.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 64.03M | -22.32% |
| Dec 31, 2024 | 82.44M | 173.36% |
| Dec 29, 2023 | 30.16M | 270.11% |
| Dec 30, 2022 | 8.15M | -73.58% |
| Dec 31, 2021 | 30.84M | -53.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 788.53B |
| UnitedHealth Group | 428.36B |
| Johnson & Johnson | 391.26B |
| Novo Nordisk | 370.84B |
| AbbVie | 358.79B |
| Abbott Laboratories | 234.29B |
| AstraZeneca | 229.50B |
| Merck & Co. | 225.36B |